These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15141268)

  • 21. Is 34 weeks an acceptable goal for a complicated singleton pregnancy?
    Jones JS; Istwan NB; Jacques D; Coleman SK; Stanziano G
    Manag Care; 2002 Oct; 11(10):42-7. PubMed ID: 12415908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Should intravenous tocolysis be considered beyond 34 weeks' gestation?
    Jones SC; Brost BC; Brehm WT
    Am J Obstet Gynecol; 2000 Aug; 183(2):356-60. PubMed ID: 10942469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Women receiving 17-alpha-hydroxyprogesterone caproate hospitalized for preterm labor at less than 34 weeks benefit from daily perinatal nursing surveillance.
    Rittenberg C; Sullivan S; Istwan N; Rhea D; Stanziano G; Newman R
    Am J Obstet Gynecol; 2008 Oct; 199(4):389.e1-4. PubMed ID: 18928983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tocolysis in women with preterm labor between 32 0/7 and 34 6/7 weeks of gestation: a randomized controlled pilot study.
    How HY; Zafaranchi L; Stella CL; Recht K; Maxwell RA; Sibai BM; Spinnato JA
    Am J Obstet Gynecol; 2006 Apr; 194(4):976-81. PubMed ID: 16580286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cervical dilatation on presentation for preterm labor and subsequent preterm birth.
    How HY; Khoury JC; Sibai BM
    Am J Perinatol; 2009 Jan; 26(1):1-6. PubMed ID: 19021099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral nifedipine maintenance therapy after acute intravenous tocolysis in preterm labor.
    Sayin NC; Varol FG; Balkanli-Kaplan P; Sayin M
    J Perinat Med; 2004; 32(3):220-4. PubMed ID: 15188794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atosiban versus usual care for the management of preterm labor.
    Husslein P; Cabero Roura L; Dudenhausen JW; Helmer H; Frydman R; Rizzo N; Schneider D
    J Perinat Med; 2007; 35(4):305-13. PubMed ID: 17614750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of preterm delivery with calcium channel blockers--Nifedipine].
    Nikolov A; Markov D; Dimitrov A; Ivanov S; Diavolov V
    Akush Ginekol (Sofiia); 2007; 46(9):18-22. PubMed ID: 18642559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does fetal fibronectin use in the diagnosis of preterm labor affect physician behavior and health care costs? A randomized trial.
    Grobman WA; Welshman EE; Calhoun EA
    Am J Obstet Gynecol; 2004 Jul; 191(1):235-40. PubMed ID: 15295372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tocolytic therapy and clinical experience. Combination therapy.
    Ingemarsson I
    BJOG; 2005 Mar; 112 Suppl 1():89-93. PubMed ID: 15715603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guidelines for the management of spontaneous preterm labor.
    Di Renzo GC; Roura LC;
    J Perinat Med; 2006; 34(5):359-66. PubMed ID: 16965221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subcutaneous tocolytic infusion therapy for patients at very high risk for preterm birth.
    Allbert JR; Wise CA; Lou CH; Gookin KS; Parmenter MA; Morrison JC
    J Perinatol; 1992 Mar; 12(1):28-31. PubMed ID: 1348530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized comparison of intravenous terbutaline vs nitroglycerin for acute intrapartum fetal resuscitation.
    Pullen KM; Riley ET; Waller SA; Taylor L; Caughey AB; Druzin ML; El-Sayed YY
    Am J Obstet Gynecol; 2007 Oct; 197(4):414.e1-6. PubMed ID: 17904983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arg16 homozygosity of the beta2-adrenergic receptor improves the outcome after beta2-agonist tocolysis for preterm labor.
    Landau R; Morales MA; Antonarakis SE; Blouin JL; Smiley RM
    Clin Pharmacol Ther; 2005 Dec; 78(6):656-63. PubMed ID: 16338281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The occurrence of adverse events in women receiving continuous subcutaneous terbutaline therapy.
    Elliott JP; Istwan NB; Rhea D; Stanziano G
    Am J Obstet Gynecol; 2004 Oct; 191(4):1277-82. PubMed ID: 15507953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized multicenter study to determine the efficacy of activity restriction for preterm labor management in patients testing negative for fetal fibronectin.
    Elliott JP; Miller HS; Coleman S; Rhea D; Abril D; Hallbauer K; Istwan NB; Stanziano GJ
    J Perinatol; 2005 Oct; 25(10):626-30. PubMed ID: 16107874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Success rate of terbutaline in inhibiting preterm labor for 48 h.
    Theplib A; Phupong V
    J Matern Fetal Neonatal Med; 2016 Mar; 29(5):841-4. PubMed ID: 25758629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retrospective analysis of the effects of ritodrine and terbutaline in the management of preterm labor.
    Weiss MA
    Clin Pharm; 1982; 1(5):453-6. PubMed ID: 7184677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tocolysis for recurrent preterm labor using a continuous subcutaneous infusion pump.
    Allbert JR; Johnson C; Roberts WE; Martin RW; Gookin KS; Morrison JC
    J Reprod Med; 1994 Aug; 39(8):614-8. PubMed ID: 7996525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management options in women with preterm uterine contractions: a randomized clinical trial.
    Guinn DA; Goepfert AR; Owen J; Brumfield C; Hauth JC
    Am J Obstet Gynecol; 1997 Oct; 177(4):814-8. PubMed ID: 9369825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.